Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antibody induction by influenza vaccines in the elderly: a review of the literature

Identifieur interne : 000166 ( 1968/Analysis ); précédent : 000165; suivant : 000167

Antibody induction by influenza vaccines in the elderly: a review of the literature

Auteurs : Walter E. P. Beyer [Pays-Bas] ; Abraham M. Palache [Pays-Bas] ; Machteld Baljet [Pays-Bas] ; Nic Masurel [Pays-Bas]

Source :

RBID : ISTEX:5ABFEFFC3E631EDDC93EDF9F98E93D0EE91EFCF8

English descriptors

Abstract

Abstract: Conflicting results have been reported concerning the association between high age and response to influenza vaccines. Some authors have found a reduced response in aged subjects, others have found no difference or even better results as compared with younger control subjects. Seventeen papers were selected from international literature published in the period 1968–1988 for a review of the anti-haemagglutinin-IgG sero-response following vaccination: among 30 cases in which vaccine components could be studied independently, ten revealed a better immune response in young subjects than in the elderly, four found more favourable results in the elderly, and 16 could not detect any significant between-group-differences, the latter most probably because of a high type-2-error. Nine of these 16 cases tended to favour young subjects. These results were relativated by the finding that each paper had at least one of three methodological limitations: (1) the failure to exclude subjects with illnesses or using drugs influencing the immune system, (2) the failure to exclude subjects with previous vaccinations against influenza, (3) the failure to exclude subjects with high prevaccination antibody titres. The direction of these biases is such that failure to address any one issue will lead to an underestimate of the response of aged subjects. In view of the failure to control these biases, it was not surprising that the papers reviewed presented a heterogeneous picture. Thus, the association between high age per se and response to influenza vaccines, if any, has not yet been established. Suggestions are made for future studies in which admission criteria should control health state and previous exposure to influenza antigens.

Url:
DOI: 10.1016/0264-410X(89)90150-3


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:5ABFEFFC3E631EDDC93EDF9F98E93D0EE91EFCF8

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Antibody induction by influenza vaccines in the elderly: a review of the literature</title>
<author>
<name sortKey="Beyer, Walter E P" sort="Beyer, Walter E P" uniqKey="Beyer W" first="Walter E. P." last="Beyer">Walter E. P. Beyer</name>
</author>
<author>
<name sortKey="Palache, Abraham M" sort="Palache, Abraham M" uniqKey="Palache A" first="Abraham M." last="Palache">Abraham M. Palache</name>
</author>
<author>
<name sortKey="Baljet, Machteld" sort="Baljet, Machteld" uniqKey="Baljet M" first="Machteld" last="Baljet">Machteld Baljet</name>
</author>
<author>
<name sortKey="Masurel, Nic" sort="Masurel, Nic" uniqKey="Masurel N" first="Nic" last="Masurel">Nic Masurel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5ABFEFFC3E631EDDC93EDF9F98E93D0EE91EFCF8</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1016/0264-410X(89)90150-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-5RSV617S-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C60</idno>
<idno type="wicri:Area/Istex/Curation">000C60</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E89</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E89</idno>
<idno type="wicri:doubleKey">0264-410X:1989:Beyer W:antibody:induction:by</idno>
<idno type="wicri:Area/Main/Merge">002272</idno>
<idno type="wicri:Area/Main/Curation">002168</idno>
<idno type="wicri:Area/Main/Exploration">002168</idno>
<idno type="wicri:Area/1968/Extraction">000166</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Antibody induction by influenza vaccines in the elderly: a review of the literature</title>
<author>
<name sortKey="Beyer, Walter E P" sort="Beyer, Walter E P" uniqKey="Beyer W" first="Walter E. P." last="Beyer">Walter E. P. Beyer</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Virology and WHO Influenza Centre, Erasmus University, PO Box 1738, 3000 DR Rotterdam</wicri:regionArea>
<wicri:noRegion>3000 DR Rotterdam</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Palache, Abraham M" sort="Palache, Abraham M" uniqKey="Palache A" first="Abraham M." last="Palache">Abraham M. Palache</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Duphar BV, Department of Clinical Research, Weesp</wicri:regionArea>
<wicri:noRegion>Weesp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baljet, Machteld" sort="Baljet, Machteld" uniqKey="Baljet M" first="Machteld" last="Baljet">Machteld Baljet</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Duphar BV, Department of Clinical Research, Weesp</wicri:regionArea>
<wicri:noRegion>Weesp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Masurel, Nic" sort="Masurel, Nic" uniqKey="Masurel N" first="Nic" last="Masurel">Nic Masurel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Virology and WHO Influenza Centre, Erasmus University, PO Box 1738, 3000 DR Rotterdam</wicri:regionArea>
<wicri:noRegion>3000 DR Rotterdam</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1989">1989</date>
<biblScope unit="volume">7</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="385">385</biblScope>
<biblScope unit="page" to="394">394</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Absolute differences</term>
<term>Active immunization</term>
<term>Admission criteria</term>
<term>Antibody</term>
<term>Antibody production</term>
<term>Antibody response</term>
<term>Antibody responses</term>
<term>Antibody titres</term>
<term>Antigenic drift</term>
<term>Beyer</term>
<term>Biol</term>
<term>Birth date</term>
<term>Bivalent vaccine</term>
<term>Booster vaccination</term>
<term>Cancer chemotherapy</term>
<term>Chlamydial infections</term>
<term>Control group</term>
<term>Control groups</term>
<term>Cystic fibrosis</term>
<term>Diagnostic procedures</term>
<term>Dos</term>
<term>Elderly</term>
<term>Elderly people</term>
<term>Elderly persons</term>
<term>Elderly population</term>
<term>Experimental trials</term>
<term>Field trials</term>
<term>Group composition</term>
<term>Groups vaccinated</term>
<term>Haemagglutinin</term>
<term>Health association</term>
<term>Health state</term>
<term>Heterogeneous picture</term>
<term>High concentrations</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immune response study</term>
<term>Immune system</term>
<term>Immunization</term>
<term>Immunogerontological studies</term>
<term>Influenza</term>
<term>Influenza antigens</term>
<term>Influenza immunization</term>
<term>Influenza infection</term>
<term>Influenza vaccination</term>
<term>Influenza vaccine</term>
<term>Influenza vaccines</term>
<term>Influenza virus vaccine</term>
<term>Influenza viruses</term>
<term>Laboratory tests</term>
<term>Latter strain</term>
<term>Major groups</term>
<term>Medical research council</term>
<term>Natural infection</term>
<term>Neutralization test</term>
<term>October</term>
<term>Original data</term>
<term>Original paper</term>
<term>Original papers</term>
<term>Other papers</term>
<term>Pneumococcal vaccine</term>
<term>Postvaccination sera</term>
<term>Postvaccination titres</term>
<term>Prevaccination</term>
<term>Prevaccination antibody</term>
<term>Prevaccination state</term>
<term>Previous exposure</term>
<term>Previous vaccinations</term>
<term>Protection rate</term>
<term>Protection rates</term>
<term>Protection threshold</term>
<term>Quantitative methods</term>
<term>Response rate</term>
<term>Response rates</term>
<term>Selection biases</term>
<term>Senieur protocol</term>
<term>Serological</term>
<term>Serological response</term>
<term>Serological results</term>
<term>Seroresponse</term>
<term>Seroresponse measures</term>
<term>Seroresponse variables</term>
<term>Serum antibody</term>
<term>Sign stat</term>
<term>Significance level</term>
<term>Significant differences</term>
<term>Slight tendency</term>
<term>Statistical calculations</term>
<term>Stratification</term>
<term>Stratification criteria</term>
<term>Streptococcus pneumoniae</term>
<term>Study design</term>
<term>Study groups</term>
<term>Study populations</term>
<term>Study subjects</term>
<term>Subunit</term>
<term>Subunit vaccines</term>
<term>Tetanus toxoid</term>
<term>Titre</term>
<term>Unprotected subjects</term>
<term>Vaccinated</term>
<term>Vaccination</term>
<term>Vaccination trials</term>
<term>Vaccine</term>
<term>Vaccine component</term>
<term>Vaccine components</term>
<term>Vaccine efficacy</term>
<term>Vaccine strain</term>
<term>Viral</term>
<term>Viral haemagglutinin</term>
<term>Viral infections</term>
<term>Virus vaccines</term>
<term>Whole virus vaccine</term>
<term>World health organization</term>
<term>Young adults</term>
<term>Young group</term>
<term>Young groups</term>
<term>Young study groups</term>
<term>Young subjects</term>
<term>Younger control subjects</term>
<term>Younger groups</term>
<term>Younger subjects</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Conflicting results have been reported concerning the association between high age and response to influenza vaccines. Some authors have found a reduced response in aged subjects, others have found no difference or even better results as compared with younger control subjects. Seventeen papers were selected from international literature published in the period 1968–1988 for a review of the anti-haemagglutinin-IgG sero-response following vaccination: among 30 cases in which vaccine components could be studied independently, ten revealed a better immune response in young subjects than in the elderly, four found more favourable results in the elderly, and 16 could not detect any significant between-group-differences, the latter most probably because of a high type-2-error. Nine of these 16 cases tended to favour young subjects. These results were relativated by the finding that each paper had at least one of three methodological limitations: (1) the failure to exclude subjects with illnesses or using drugs influencing the immune system, (2) the failure to exclude subjects with previous vaccinations against influenza, (3) the failure to exclude subjects with high prevaccination antibody titres. The direction of these biases is such that failure to address any one issue will lead to an underestimate of the response of aged subjects. In view of the failure to control these biases, it was not surprising that the papers reviewed presented a heterogeneous picture. Thus, the association between high age per se and response to influenza vaccines, if any, has not yet been established. Suggestions are made for future studies in which admission criteria should control health state and previous exposure to influenza antigens.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
</list>
<tree>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Beyer, Walter E P" sort="Beyer, Walter E P" uniqKey="Beyer W" first="Walter E. P." last="Beyer">Walter E. P. Beyer</name>
</noRegion>
<name sortKey="Baljet, Machteld" sort="Baljet, Machteld" uniqKey="Baljet M" first="Machteld" last="Baljet">Machteld Baljet</name>
<name sortKey="Masurel, Nic" sort="Masurel, Nic" uniqKey="Masurel N" first="Nic" last="Masurel">Nic Masurel</name>
<name sortKey="Palache, Abraham M" sort="Palache, Abraham M" uniqKey="Palache A" first="Abraham M." last="Palache">Abraham M. Palache</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/1968/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000166 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/1968/Analysis/biblio.hfd -nk 000166 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    1968
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:5ABFEFFC3E631EDDC93EDF9F98E93D0EE91EFCF8
   |texte=   Antibody induction by influenza vaccines in the elderly: a review of the literature
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021